A prospective study of plasma ferritin level and incident diabetes - The Atherosclerosis Risk in Communities (ARIC) Study

被引:101
作者
Jehn, Megan L.
Guallar, Eliseo
Clark, Jeanne M.
Couper, David
Duncan, Bruce B.
Ballantyne, Christie M.
Hoogeveen, Ron C.
Harris, Z. Leah
Pankow, James S.
机构
[1] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Johns Hopkins Med Inst, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Arizona State Univ, WP Carey Sch Business, Sch Hlth Management & Policy, Tempe, AZ USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA
[6] Univ Fed Rio Grande do Sul, Sch Med, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil
[7] Baylor Coll Med, Dept Med, Ctr Cardiovasc Dis Prevent, Houston, TX 77030 USA
[8] Johns Hopkins Med Inst, Dept Anesthesiol, Baltimore, MD 21205 USA
[9] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
关键词
cohort studies; diabetes mellitus; type; 2; ferritins; incidence; iron;
D O I
10.1093/aje/kwk093
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The authors performed a case-cohort study nested within the Atherosclerosis Risk in Communities (ARIC) Study to determine the association between plasma ferritin level and risk of type 2 diabetes mellitus. Persons with incident cases of type 2 diabetes diagnosed over an average follow-up period of 7.9 years (n = 599) were compared with a random sample of the cohort (n = 690). After adjustment for age, gender, menopausal status, ethnicity, center, smoking, and alcohol intake, the hazard ratio for diabetes, comparing the fifth quintile of ferritin with the first quintile, was 1.74 (95% confidence interval: 1.14, 2.65; p-trend < 0.001). After further adjustment for body mass index and components of the metabolic syndrome, the hazard ratio was 0.81 (95% confidence interval: 0.49, 1.34; p-trend 0.87). From a causal perspective, there are two alternative interpretations of these findings. Elevated iron stores, reflected in elevated plasma ferritin levels, may induce baseline metabolic abnormalities that ultimately result in diabetes. Alternatively, elevated ferritin may be just one of several metabolic abnormalities related to the underlying process that ultimately results in diabetes, rather than a causal factor for diabetes. Longitudinal studies with repeated measurements of glucose and iron metabolism parameters are needed to establish the role of iron stores and plasma ferritin in diabetes development.
引用
收藏
页码:1047 / 1054
页数:8
相关论文
共 49 条
[1]  
BALLA G, 1992, J BIOL CHEM, V267, P18148
[2]   Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes [J].
Caballero A.E. .
Current Diabetes Reports, 2004, 4 (4) :237-246
[3]   Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis:: assessment by oral glucose tolerance test [J].
Cario, H ;
Holl, RW ;
Debatin, KMM ;
Kohne, E .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (03) :139-146
[4]   INSULIN-RESISTANCE AND HYPERINSULINEMIA IN HOMOZYGOUS BETA-THALASSEMIA [J].
CAVALLOPERIN, P ;
PACINI, G ;
CERUTTI, F ;
BESSONE, A ;
CONDO, C ;
SACCHETTI, L ;
PIGA, A ;
PAGANO, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (03) :281-286
[5]   Risk factors for progression of common carotid atherosclerosis: The atherosclerosis risk in communities study, 1987-1998 [J].
Chambless, LE ;
Folsom, AR ;
Davis, V ;
Sharrett, R ;
Heiss, G ;
Sorlie, P ;
Szklo, M ;
Howard, G ;
Evans, GW .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (01) :38-47
[6]   Association between inflammation and insulin resistance in US nondiabetic adults - Results from the Third National Health and Nutrition Examination Survey [J].
Chen, J ;
Wildman, RP ;
Hamm, LL ;
Muntner, P ;
Reynolds, K ;
Whelton, PK ;
He, J .
DIABETES CARE, 2004, 27 (12) :2960-2965
[7]   Hepatic steatosis and type 2 diabetes mellitus. [J].
Clark J.M. ;
Diehl A.M. .
Current Diabetes Reports, 2002, 2 (3) :210-215
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   Coronary heart disease and iron status - Meta-analyses of prospective studies [J].
Danesh, J ;
Appleby, P .
CIRCULATION, 1999, 99 (07) :852-854
[10]   Mechanisms of endothelial dysfunction in the metabolic syndrome [J].
Prakash C. Deedwania .
Current Diabetes Reports, 2003, 3 (4) :289-292